Some evidence suggests a positive association between prediagnostic serum leptin and risk of cancer for colorectal 31, breast 8, prostate 32, and endometrial cancer 33, as well as renal cell carcinoma 4, but results are contradictory 34, 35. This evidence concerns the gene LEP and cancer.